Details of the Drug

General Information of Drug (ID: DMINAG4)

Drug Name

Meglumine antimoniate

Synonyms

Glucantime; Methylglucamine antimonate; Meglumine antimonate; Protostib; 133-51-7; meglumine antimoniate; N-Methylglucamine antimonate; UNII-75G4TW236W; 2168-RP; EINECS 205-108-3; N-Methylgluamine Antimoniate; 1-Deoxy-1-(methylamino)glucitol antimonate(V); 75G4TW236W; D-Glucitol, 1-deoxy-1-(methylamino)-, trioxoantimonate(1-); 1-Deoxy-1-(methylamino)-D-glucitol, compound with antimonic acid (1:1); D-Glucitol, 1-deoxy-1-(methylamino)-, compd. with antimonic acid (1:1); Glucitol, 1-deoxy-1-(methylamino)-, compd. with antimon

Indication

Disease Entry	ICD 11	Status	REF
Leishmania braziliensis infection	1F54.2	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C7H18NO8Sb
Canonical SMILES: CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O
InChI: 1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1
InChIKey: XOGYVDXPYVPAAQ-SESJOKTNSA-M

Cross-matching ID

PubChem CID: 64953
CAS Number: 133-51-7
TTD ID: D0T6VD

Combinatorial Drugs (CBD)

Click to Jump to the Detailed CBD Information of This Drug

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015